Delivery Order SPE2DB24D2205-SPE2DB25FEGKV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.80 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price delivery order, effective through August 12, 2025, represents a competitively awarded, non-set-aside procurement issued on August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.08 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This firm fixed-price contract, issued on August 7, 2025, is a non-set-aside award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is firm fixed price with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $5,156.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGKVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,106.94 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is a firm fixed price delivery order with no set-aside designation, issued on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The company's DLA IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Dexcom G7 sensors reflects the company's role in supplying specialized medical devices and diabetes management solutions to support Defense Health Agency operations and other federal healthcare customers through the DLA's comprehensive pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/18/25 |